Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Maintenance of weight loss in adolescents: current status and future directions.

Butryn ML, Wadden TA, Rukstalis MR, Bishop-Gilyard C, Xanthopoulos MS, Louden D, Berkowitz RI.

J Obes. 2010;2010:789280. doi: 10.1155/2010/789280. Epub 2011 Jan 2.

2.

Effectiveness of weight management programs in children and adolescents.

Whitlock E, O'Connor E, Williams S, Beil T, Lutz K.

Evid Rep Technol Assess (Full Rep). 2008 Sep;(170):1-308. Review.

3.

Lifestyle intervention for improving school achievement in overweight or obese children and adolescents.

Martin A, Saunders DH, Shenkin SD, Sproule J.

Cochrane Database Syst Rev. 2014 Mar 14;(3):CD009728. doi: 10.1002/14651858.CD009728.pub2. Review.

PMID:
24627300
4.

Treatment of obesity in children and adolescents.

Matson KL, Fallon RM.

J Pediatr Pharmacol Ther. 2012 Jan;17(1):45-57. doi: 10.5863/1551-6776-17.1.45.

5.

Pharmacological approaches for management of child and adolescent obesity.

Kanekar A, Sharma M.

J Clin Med Res. 2010 May 19;2(3):105-11. doi: 10.4021/jocmr2010.05.288w.

6.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

7.

Drug interventions for the treatment of obesity in children and adolescents.

Mead E, Atkinson G, Richter B, Metzendorf MI, Baur L, Finer N, Corpeleijn E, O'Malley C, Ells LJ.

Cochrane Database Syst Rev. 2016 Nov 29;11:CD012436. Review.

PMID:
27899001
8.

Long-term pharmacotherapy for obesity and overweight.

Padwal R, Li SK, Lau DC.

Cochrane Database Syst Rev. 2004;(3):CD004094. Review.

PMID:
15266516
9.

Long-term pharmacotherapy for obesity and overweight.

Padwal R, Li SK, Lau DC.

Cochrane Database Syst Rev. 2003;(4):CD004094. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD004094.

PMID:
14584004
10.

A comparison of meal replacements and medication in weight maintenance after weight loss.

LeCheminant JD, Jacobsen DJ, Hall MA, Donnelly JE.

J Am Coll Nutr. 2005 Oct;24(5):347-53.

PMID:
16192259
11.

Effectiveness of a lifestyle modification programme in weight maintenance in obese subjects after cessation of treatment with Orlistat.

Woo J, Sea MM, Tong P, Ko GT, Lee Z, Chan J, Chow FC.

J Eval Clin Pract. 2007 Dec;13(6):853-9.

PMID:
18070255
12.

Treatment of obesity: a challenging task.

Sharma AM, Iacobellis G.

Contrib Nephrol. 2006;151:212-20. Review.

PMID:
16929144
13.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity.

O'Meara S, Riemsma R, Shirran L, Mather L, ter Riet G.

Health Technol Assess. 2001;5(18):1-81. Review.

14.

Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adults.

Mastellos N, Gunn LH, Felix LM, Car J, Majeed A.

Cochrane Database Syst Rev. 2014 Feb 5;(2):CD008066. doi: 10.1002/14651858.CD008066.pub3. Review.

PMID:
24500864
15.

Systematic reviews of and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men.

Robertson C, Archibald D, Avenell A, Douglas F, Hoddinott P, van Teijlingen E, Boyers D, Stewart F, Boachie C, Fioratou E, Wilkins D, Street T, Carroll P, Fowler C.

Health Technol Assess. 2014 May;18(35):v-vi, xxiii-xxix, 1-424. doi: 10.3310/hta18350. Review.

16.

[Psychotherapy in obesity--a systematic review].

Becker S, Rapps N, Zipfel S.

Psychother Psychosom Med Psychol. 2007 Nov;57(11):420-7. Review. German.

PMID:
17948205
17.

Lifestyle modification for the management of obesity.

Wadden TA, Butryn ML, Wilson C.

Gastroenterology. 2007 May;132(6):2226-38. Review. Erratum in: Gastroenterology. 2007 Jul;133(1):371.

PMID:
17498514
18.

Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association.

Kelly AS, Barlow SE, Rao G, Inge TH, Hayman LL, Steinberger J, Urbina EM, Ewing LJ, Daniels SR; American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young, Council on Nutrition, Physical Activity and Metabolism, and Council on Clinical Cardiology.

Circulation. 2013 Oct 8;128(15):1689-712. doi: 10.1161/CIR.0b013e3182a5cfb3. Epub 2013 Sep 9.

19.

Efficacy of lifestyle modification for long-term weight control.

Wadden TA, Butryn ML, Byrne KJ.

Obes Res. 2004 Dec;12 Suppl:151S-62S. Review.

20.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. Review.

Supplemental Content

Support Center